Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in fluorescent probes for guided surgery of head and neck carcinomas.

RSC advances·2026
Same author

The influence of structural diversity in polymer-based nanomedicines on anti-cancer efficacy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Polymeric Theranostics with Tetraphenylporphyrin for Effective Low-Dose Photodynamic Cancer Therapy.

Pharmaceutics·2026
Same author

CD64-Targeted Polymer-Drug Conjugates Exploit Cathepsin K-Dependent Payload Release for Selective Elimination of Immunosuppressive Macrophages.

Molecular pharmaceutics·2026
Same author

Ciprofloxacin-polymer conjugates targeted with iron(III) for effective treatment of intracellular bacterial infections.

Biomaterials science·2026
Same author

Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Jun 22, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

HPMA-based polymer conjugates with drug combination.

Hana Krakovicová1, Tomás Etrych, Karel Ulbrich

  • 1Institute of Macromolecular Chemistry Academy of Sciences of the Czech Republic v.v.i., Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic. krakovicova@imc.cas.cz

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|June 4, 2009
PubMed
Summary
This summary is machine-generated.

New polymer-drug conjugates carrying both doxorubicin and dexamethasone were synthesized for dual cancer therapy. These conjugates show pH-sensitive drug release in simulated intracellular environments, enhancing therapeutic potential.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

Related Experiment Videos

Last Updated: Jun 22, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

Area of Science:

  • Polymer Chemistry
  • Medicinal Chemistry
  • Bioconjugation

Background:

  • Polymer-drug conjugates offer targeted delivery and controlled release of therapeutics.
  • Developing dual-action conjugates can enhance efficacy and overcome resistance in cancer treatment.

Purpose of the Study:

  • To synthesize and characterize novel polymer-drug conjugates for dual cancer therapy.
  • To investigate the release kinetics of doxorubicin and dexamethasone from the polymer backbone under different physiological conditions.

Main Methods:

  • Covalent attachment of doxorubicin (DOX) and dexamethasone (DEX) to an N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer backbone using pH-sensitive hydrazone bonds.
  • Synthesis of DEX derivatives (4-oxopentanoate and 4-(2-oxopropyl)benzoate esters) for conjugation.
  • Physico-chemical characterization of the synthesized polymer-drug conjugates.
  • In vitro drug release studies in buffers simulating intracellular and bloodstream environments, including enzymatic hydrolysis.

Main Results:

  • Successful synthesis of polymer conjugates with dual (DOX and DEX) or single drug loading.
  • Physico-chemical properties varied based on drug type, spacer structure, and drug loading.
  • Significantly faster drug release (DOX) and drug derivative release (DEX) in simulated intracellular environments compared to blood conditions.
  • Demonstrated susceptibility of DEX conjugates to enzymatic hydrolysis, indicating a two-step release mechanism.

Conclusions:

  • Novel polymer-drug conjugates with dual therapeutic potential were successfully developed.
  • The pH-sensitive hydrazone linkage enables controlled drug release, favoring intracellular environments.
  • These findings support the potential of these conjugates for enhanced cancer therapy through targeted and dual-action drug delivery.